BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24008552)

  • 1. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
    Wu Y; Guo Z; Zhang D; Zhang W; Yan Q; Shi X; Zhang M; Zhao Y; Zhang Y; Jiang B; Cheng T; Bai Y; Wang J
    Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
    Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
    Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth.
    Zhong MA; Zhang H; Qi XY; Lu AG; You TG; Gao W; Guo XL; Zhou ZQ; Yang Y; Wang CJ
    Mol Med Rep; 2011; 4(5):805-10. PubMed ID: 21725599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29.
    Amann T; Egle Y; Bosserhoff AK; Hellerbrand C
    Oncol Rep; 2010 Jun; 23(6):1669-74. PubMed ID: 20428824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
    Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
    Liu Y; Shen Y; Qin C; Shi Y; Rong G; Yu X
    Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
    Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
    Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
    Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
    Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
    Diao Y; Ma J; Li X; Sun X; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological behaviour of colon cancer cells transfected with C-erbB2 shRNA plasmid].
    Zhao DL; Dang CX; Sui YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):371-3. PubMed ID: 22482406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
    Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.